格隆匯3.16盤前要點丨音頻
格隆匯3月16日丨1、美股三大指數集體收漲 熱門中概股大幅反彈;
2、國際原油較一週前高點累跌逾20% 黃金期貨創半個月收盤新低;
3、烏總統辦公室主任顧問:俄烏談判16日將繼續進行 雙方存在妥協可能;
4、衞健委發佈第九版新型冠狀病毒肺炎診療方案:對病例實施分類收治,進一步規範抗病毒治療;
5、央視315晚會點名這些公司;
6、香港新增新冠確診病例27765例 死亡病例294例 港大:第五波疫情已達頂峯;
7、北上資金淨賣出貴州茅台27億元;
8、南下資金淨買入騰訊57.44億港元 連續11日共計淨買入超184億港元;
9、澳門政府料在博彩公司批給合同列重大財務決定通知準則;
10、國家藥監局新批准兩家新冠抗原自測產品上市;
11、比亞迪對部分車型再次調價 上調幅度3000元-6000元;
12、斯瑞新材(688102.SH)今日上市;“粵式火鍋一哥”撈王港交所遞表衝刺IPO。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.